The Efficacy of Platelet-Rich Plasma in Osseous Foot and Ankle Pathology: A Review

Johnson, Lindsey G; Buck, Erin H; Anastasio, Albert T.; Abar, Bijan; Fletcher, Amanda N.; Adams, Samuel B.

doi:10.2217/rme-2022-0056

Cited by 2 publications

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PRP has been shown to be effective in the treatment of short bone disease [16,17]. However, its efficacy associated with the treatment of cartilage lesions in the lower limb is uncertain [18]. In patients with Hepple IV-V stage of MRI classification, talus osteochondral transplantation is the preferred treatment.…”

Section: Introductionmentioning

confidence: 99%

Analysis of factors affecting the prognosis of osteochondral lesions of the talus

Bai

Zhang

Chen

et al. 2022

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

Purpose This study aims to analyze the correlation between the prognosis of osteochondral lesions of the talus and patient age, gender, duration of illness, and injury location, surface area, depth, and volume. Methods A retrospective analysis of 44 patients who underwent talus osteochondral transplantation in the Department of Foot and Ankle Surgery of our hospital between January 2017 and December 2020 was performed. The clinical medical records of the patients were collected, and the location of the osteochondral lesion of the talus was determined according to the nine-division method. The surface area, depth, and volume of the osteochondral lesion of the talus were measured using mimics software in all patients. The visual analog scale (VAS), the American Orthopedic Foot and Ankle Society (AOFAS), and the SF-36 quality of life questionnaire scores were evaluated before surgery and at the last follow-up, and correlation analysis was performed. Results Of 44 patients, 30 were followed up with a mean period of 24.33 ± 12.19 months. There were 18 men and 12 women, with an average age of 40.73 ± 10.57 years and an average disease duration of 28.30 ± 21.25 months. The VAS, AOFAS, and SF-36 scores of all patients at the last follow-up were significantly better than those before surgery. The degree of post-operative symptom improvement was not correlated with age, sex, duration of illness, and injury location, surface area, depth, and volume. Conclusion The prognosis of osteochondral lesion of the talus is not related to patient age, gender, duration of disease, or injury location, surface area, depth, and volume.

show abstract

Section: Introductionmentioning

confidence: 99%